Eir Ventures Closes Life Science Venture Fund at EUR122 million
New Nordic fund focused on high-impact medical innovation
Nine investments made over the first 16 months in early and late-stage healthcare companies. Two
portfolio companies IPO’ed on NASDAQ New York
December 9, 2021, Stockholm & Copenhagen: Eir Ventures Partners AB (“Eir Ventures” or “the
Fund”), a Nordic Life Science Venture Capital manager, today announced the final close of its fund Eir
Ventures I AB of EUR 122.3 million.
